317 Labs, Inc. — Form D/A
317 Labs, Inc. of Los Angeles, CA, a company, filed a Form D amendment with the SEC on 2022-03-02. The offering totals $76.5M, of which $67.2M was reported sold. Industry: Other Technology.
Offering
- Filed: 2022-03-02
- Form: D/A
- Accession: 0001792974-22-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $76.5M
- Amount sold: $67.2M
- Remaining: $9.3M
- Investors: 19
- Date of first sale: 2021-01-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-388049
Issuer
- Name: 317 Labs, Inc.
- CIK: 0001792974
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 11390 West Olympic Boulevard, Los Angeles, CA, 90064
- Phone: 818-522-6841
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Sabri Murat Bicer | Director | San Francisco, CA |
| Omar Hamoui | Director | New York, NY |
| Zachary Wise | Director | Los Angeles, CA |
| Brian Zatulove | Director | Los Angeles, CA |
| Zachary Wise | Executive Officer | Los Angeles, CA |
| Brian Zatulove | Executive Officer | Los Angeles, CA |
| Murat Bicer | Director | Palo Alto, CA |
Other filings by this issuer (3)
More